<code id='69824BEEFE'></code><style id='69824BEEFE'></style>
    • <acronym id='69824BEEFE'></acronym>
      <center id='69824BEEFE'><center id='69824BEEFE'><tfoot id='69824BEEFE'></tfoot></center><abbr id='69824BEEFE'><dir id='69824BEEFE'><tfoot id='69824BEEFE'></tfoot><noframes id='69824BEEFE'>

    • <optgroup id='69824BEEFE'><strike id='69824BEEFE'><sup id='69824BEEFE'></sup></strike><code id='69824BEEFE'></code></optgroup>
        1. <b id='69824BEEFE'><label id='69824BEEFE'><select id='69824BEEFE'><dt id='69824BEEFE'><span id='69824BEEFE'></span></dt></select></label></b><u id='69824BEEFE'></u>
          <i id='69824BEEFE'><strike id='69824BEEFE'><tt id='69824BEEFE'><pre id='69824BEEFE'></pre></tt></strike></i>

          
          WSS
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          Wikipedia